The home care M&A market continues to evolve in 2026. After a period of multiple compression in 2022–2023 driven by rising interest rates and macroeconomic uncertainty, the market has stabilized — and in certain segments, transaction volumes and valuations are approaching or exceeding their prior peaks.
This market update reflects our current view of conditions across the major home care segments. It is intended for agency owners who are assessing market timing for a sale, and for advisors who want a current-conditions framework.
Buyer activity remains strong. Despite a higher interest rate environment than the 2020–2021 peak, PE-backed platforms remain highly acquisitive. The demographic tailwind — an aging population, growing preference for home-based care, CMS and payer push toward community-based settings — continues to make home care attractive as a long-term investment thesis.
Strategic buyers are also active. Larger strategic acquirers (multi-state home care chains, health systems, post-acute networks) are making selective acquisitions where geographic expansion or service line diversification creates strategic value.
Selectivity has increased. The frothy 2020–2021 market, when almost any home care agency with positive EBITDA could attract multiple buyer offers, has given way to a more selective environment. Buyers are more disciplined about quality: they evaluate compliance history, management depth, growth trajectory, and operational quality more carefully. Average agencies receive average offers; excellent agencies attract multiple competing offers.
Market conditions: Active. The private pay segment continues to attract PE interest for several reasons: no payer reimbursement dependency, demographic demand clarity, and scalable organic growth potential in most markets.
Multiples:
Key buyer characteristics: PE buyers are generally looking for private pay agencies with $500K+ EBITDA, strong management teams, diversified referral sources, and markets with favorable demographics and limited direct competition.
What’s working well: Geographic concentration building (buyers want density in specific metro areas), technology-forward operators, and agencies with strong brand and online reputation.
Market conditions: Selective but with strong multiples for quality assets. The Medicare Advantage penetration reality (now 50%+ of Medicare beneficiaries) has complicated the Medicare skilled home health acquisition thesis — buyers are managing the MA vs. FFS rate differential and managing care intensity expectations from MA payers differently.
Multiples:
Buyer concerns: Medicare Advantage penetration and rate adequacy, LUPA rates, OASIS accuracy, and compliance history are the primary evaluation areas.
What’s commanding premium: Deficiency-free survey history, strong 5-star Home Health Compare ratings, CON state positioning, and established MA contracts at reasonable rates.
Market conditions: Premium multiples but intense regulatory scrutiny. Hospice remains the highest-multiple segment in post-acute care, with strong buyer interest from both PE platforms and national strategic operators.
Multiples:
Buyer concerns: CMS hospice audit activity remains heightened. Buyers scrutinize length of stay data, diagnosis coding appropriateness, physician certification documentation, and General Inpatient (GIP) utilization. Compliance history is heavily weighted.
2026 specific note: CMS’s continued focus on hospice payment reform and audit initiatives has increased buyer due diligence intensity in this sector. Clean compliance records are more important than ever.
Market conditions: Varies significantly by state. In states with favorable Medicaid reimbursement rates and growing HCBS waiver programs, buyer interest is strong. In states with ongoing rate pressure or MLTSS transition uncertainty, buyers are more cautious.
Multiples:
Key factors: State reimbursement environment, MCO contract terms, and agency quality are the primary differentiation factors.
Market conditions: Emerging as one of the higher-growth segments in home and community-based services M&A. Strong demographic drivers (aging population of IDD individuals requiring residential and HCBS support), limited competition among qualified providers, and often above-market Medicaid waiver rates in many states.
Multiples:
Key factors: State waiver availability and rates, state day services funding, residential vs. HCBS service mix, and team stability.
Market conditions: Premium segment with limited seller supply. PDN agencies remain scarce relative to buyer demand — clinical complexity, licensing requirements, and billing complexity create meaningful barriers to entry and support higher multiples.
Multiples:
Key factors: Nurse staffing stability, payer mix (technology-dependent/vent care premium), and geographic presence in underserved markets.
The base interest rate environment has normalized from 2022–2023 peaks. Current financing conditions:
PE-backed transactions: Most middle-market PE-backed acquisitions use a combination of debt (bank credit facilities, unitranche credit structures) and equity. The leverage multiples available have moderated slightly from 2020–2021 peaks but remain available for quality assets — typically 3×–5× EBITDA in debt capacity for home care platform acquisitions.
SBA financing for smaller deals: SBA 7(a) and 504 programs remain active for sub-$5M transactions, enabling smaller strategic buyers and management buyout scenarios. SBA rates have increased from 2020 lows but remain accessible.
Effect on multiples: The current rate environment is slightly more restrictive than the 2020–2021 peak period, but not dramatically so. The primary effect has been on the most leveraged large-platform transactions. Sub-$3M enterprise value transactions — the range most home care agencies trade in — are less rate-sensitive because the relative equity proportion is higher.
Based on our active deal flow, here is what differentiates the highest-value acquisitions in the current market:
1. Management team with depth beyond the founder. The post-COVID labor market has reinforced how fragile businesses dependent on a single owner/operator are. Buyers consistently premium-price agencies where a qualified management team can run operations independently.
2. Proven organic growth. Agencies growing 10–20%+ annually before the transaction tell a compelling narrative about market position and execution capability that justifies forward-looking valuations.
3. Clinical quality documentation. Survey history, quality ratings, compliance records, and patient/client satisfaction scores are scrutinized more carefully than they were 5 years ago. Agencies with documented, sustained quality performance are rewarded.
4. Technology adoption. Scheduling systems, electronic health records, digital billing infrastructure, and workforce management tools are increasingly considered baseline expectations rather than differentiators — but agencies that are notably behind technology curve face discounts.
5. Diversified referral base. No single referral source representing more than 20–25% of referrals. Documented breadth of hospital, SNF, physician, and community relationships.
6. Clean compliance track record. No open CMS audit activity, no recent survey deficiencies, no outstanding billing disputes. The less regulatory hair, the better the offer.
Labor cost trajectory. Caregiver wages have risen significantly in most markets. Buyers model forward caregiver cost increases and discount businesses they believe will face margin pressure from wage inflation.
Medicare Advantage margin compression. For skilled agencies, the continued shift to MA and the reimbursement differential vs. Medicare FFS is a concern buyers actively model.
Medicaid rate uncertainty. States facing fiscal pressure create ongoing risk for Medicaid-heavy agencies. Buyers price in some defensibility discount for state budget exposure.
Quality agencies continue to attract strong buyer interest and competitive offers — the market is not broken, it is selective.
Multiples have stabilized and in premium segments (hospice, PDN, skilled home health) remain near historic highs.
Building management depth and cleaning up compliance issues before going to market has a more significant impact on your valuation than timing the market perfectly.
The competitive process remains powerful — agencies that run a properly structured, multi-buyer process continue to achieve better outcomes than those that transact with a single buyer.
Start planning early. The best home care M&A outcomes come from owners who prepared 12–24 months before their target sale date — not those who decided to sell and expected to close quickly.
Schedule a confidential market assessment with Hendon Partners →
Hendon Partners tracks home care M&A market conditions continuously across all segments and geographies. Our advisors maintain active relationships with buyers and lenders across the market, giving us real-time insight into pricing, buyer appetite, and transaction terms.
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.
